Inflammatory bowel disease: towards a personalized medicine
M Flamant, X Roblin - Therapeutic advances in …, 2018 - journals.sagepub.com
The management of inflammatory bowel disease (IBD) has been transformed over the last
two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently …
two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently …
Inflammatory bowel disease: towards a personalized medicine.
M Flamant, X Roblin - Therapeutic Advances in …, 2018 - search.ebscohost.com
The management of inflammatory bowel disease (IBD) has been transformed over the last
two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently …
two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently …
[PDF][PDF] Inflammatory bowel disease: towards a personalized medicine
M Flamant, X Roblin - 2018 - scienceopen.com
The management of inflammatory bowel disease (IBD) has been transformed over the last
two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently …
two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently …
[HTML][HTML] Inflammatory bowel disease: towards a personalized medicine
M Flamant, X Roblin - Therapeutic Advances in Gastroenterology, 2018 - ncbi.nlm.nih.gov
The management of inflammatory bowel disease (IBD) has been transformed over the last
two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently …
two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently …
Inflammatory bowel disease: towards a personalized medicine
M Flamant, X Roblin - Therapeutic Advances in Gastroenterology, 2018 - cir.nii.ac.jp
抄録< jats: p> The management of inflammatory bowel disease (IBD) has been transformed
over the last two decades by the arrival of tumor necrosis factor (TNF) antagonist agents …
over the last two decades by the arrival of tumor necrosis factor (TNF) antagonist agents …
Inflammatory bowel disease: towards a personalized medicine
M Flamant, X Roblin - Therapeutic advances in …, 2018 - pubmed.ncbi.nlm.nih.gov
The management of inflammatory bowel disease (IBD) has been transformed over the last
two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently …
two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently …
Inflammatory bowel disease: towards a personalized medicine.
M Flamant, X Roblin - Therapeutic Advances in Gastroenterology, 2018 - europepmc.org
The management of inflammatory bowel disease (IBD) has been transformed over the last
two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently …
two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently …
Inflammatory bowel disease: towards a personalized medicine.
M Flamant, X Roblin - Therapeutic Advances in Gastroenterology, 2018 - europepmc.org
The management of inflammatory bowel disease (IBD) has been transformed over the last
two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently …
two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently …